doi:10.1371/journal.pone.0126769 Bode B, An overview of the pharmacokinetics, efficacy and safety of liraglutide
1 Clinical testing of 76 non-GLP-1 subjects after 12 weeks showed up to: +18% visible lifting, -16% global wrinkles, and +54% smoothness and average results of +7.6% lifting, -7.6% global wrinkles, and +40% smoothness improvement across all 76 subjects
The criteria for including articles in the final quantitative synthesis were as follows: 1
Common Side Effects The most frequently reported side effects of GLP-1 medications include: These side effects are typically most pronounced during the initial weeks of treatment and when doses are increased
Ali Rezaie, Medical Director of Gastroenterology Motility at Cedars-Sinai Medical Center, emphasized the need for context, noting that while the relative risk increases by 33%, the absolute risk remains low at 0.2%